Reply to “Novaferon, treatment in COVID-19 patients”

Reply to “Novaferon, treatment in COVID-19 patients”

Bibliographic Details
Main Authors: Fang Zheng, Yanwen Zhou, Zhiguo Zhou, Fei Ye, Baoying Huang, Yaxiong Huang, Jing Ma, Qi Zuo, Xin Tan, Jun Xie, Peihua Niu, Wenlong Wang, Yun Xu, Feng Peng, Ning Zhou, Chunlin Cai, Wei Tang, Xinqiang Xiao, Yi Li, Zhiguang Zhou, Yongfang Jiang, Yuanlin Xie, Wenjie Tan, Guozhong Gong
Format: Article
Language:English
Published: Elsevier 2021-02-01
Series:International Journal of Infectious Diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971220324929
id doaj-c837504a1156480baf241c2d821fd62f
record_format Article
spelling doaj-c837504a1156480baf241c2d821fd62f2021-02-07T04:21:45ZengElsevierInternational Journal of Infectious Diseases1201-97122021-02-01103336337Reply to “Novaferon, treatment in COVID-19 patients”Fang Zheng0Yanwen Zhou1Zhiguo Zhou2Fei Ye3Baoying Huang4Yaxiong Huang5Jing Ma6Qi Zuo7Xin Tan8Jun Xie9Peihua Niu10Wenlong Wang11Yun Xu12Feng Peng13Ning Zhou14Chunlin Cai15Wei Tang16Xinqiang Xiao17Yi Li18Zhiguang Zhou19Yongfang Jiang20Yuanlin Xie21Wenjie Tan22Guozhong Gong23Department of Infectious Diseases, The First Hospital of Changsha, Changsha, ChinaDepartment of Infectious Diseases, The Second Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Respiratory Medicine, The First Hospital of Changsha, Changsha, ChinaNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, ChinaNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, ChinaDepartment of Infectious Diseases, The First Hospital of Changsha, Changsha, ChinaDepartment of Infectious Diseases, The Second Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Intensive Care Unit, The First Hospital of Changsha, Changsha, ChinaDepartment of Pediatrics, The First Hospital of Changsha, Changsha, ChinaDepartment of Internal Medicine, The First Hospital of Changsha, Changsha, ChinaNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, ChinaDepartment of Infectious Diseases, The Second Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Infectious Diseases, The Second Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Infectious Diseases, The Second Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Infectious Diseases, The Second Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Infectious Diseases, The First Hospital of Changsha, Changsha, ChinaDepartment of Infectious Diseases, The First Hospital of Changsha, Changsha, ChinaDepartment of Infectious Diseases, The Second Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Infectious Diseases, The Second Xiangya Hospital, Central South University, Changsha, ChinaKey Laboratory of Diabetes Immunology (Central South University), Ministry of Education, National Clinical Research Center for Metabolic Diseases, The Second Xiangya Hospital, Central South University, Changsha, ChinaCorresponding author.; Department of Infectious Diseases, The Second Xiangya Hospital, Central South University, Changsha, 410011, ChinaCorresponding author; Department of Infectious Diseases, The First Hospital of Changsha, Changsha, ChinaCorresponding author; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, ChinaCorresponding author at: Department of Infectious Diseases, The Second Xiangya Hospital, Central South University, Changsha, 410011, China.; Department of Infectious Diseases, The Second Xiangya Hospital, Central South University, Changsha, Chinahttp://www.sciencedirect.com/science/article/pii/S1201971220324929
collection DOAJ
language English
format Article
sources DOAJ
author Fang Zheng
Yanwen Zhou
Zhiguo Zhou
Fei Ye
Baoying Huang
Yaxiong Huang
Jing Ma
Qi Zuo
Xin Tan
Jun Xie
Peihua Niu
Wenlong Wang
Yun Xu
Feng Peng
Ning Zhou
Chunlin Cai
Wei Tang
Xinqiang Xiao
Yi Li
Zhiguang Zhou
Yongfang Jiang
Yuanlin Xie
Wenjie Tan
Guozhong Gong
spellingShingle Fang Zheng
Yanwen Zhou
Zhiguo Zhou
Fei Ye
Baoying Huang
Yaxiong Huang
Jing Ma
Qi Zuo
Xin Tan
Jun Xie
Peihua Niu
Wenlong Wang
Yun Xu
Feng Peng
Ning Zhou
Chunlin Cai
Wei Tang
Xinqiang Xiao
Yi Li
Zhiguang Zhou
Yongfang Jiang
Yuanlin Xie
Wenjie Tan
Guozhong Gong
Reply to “Novaferon, treatment in COVID-19 patients”
International Journal of Infectious Diseases
author_facet Fang Zheng
Yanwen Zhou
Zhiguo Zhou
Fei Ye
Baoying Huang
Yaxiong Huang
Jing Ma
Qi Zuo
Xin Tan
Jun Xie
Peihua Niu
Wenlong Wang
Yun Xu
Feng Peng
Ning Zhou
Chunlin Cai
Wei Tang
Xinqiang Xiao
Yi Li
Zhiguang Zhou
Yongfang Jiang
Yuanlin Xie
Wenjie Tan
Guozhong Gong
author_sort Fang Zheng
title Reply to “Novaferon, treatment in COVID-19 patients”
title_short Reply to “Novaferon, treatment in COVID-19 patients”
title_full Reply to “Novaferon, treatment in COVID-19 patients”
title_fullStr Reply to “Novaferon, treatment in COVID-19 patients”
title_full_unstemmed Reply to “Novaferon, treatment in COVID-19 patients”
title_sort reply to “novaferon, treatment in covid-19 patients”
publisher Elsevier
series International Journal of Infectious Diseases
issn 1201-9712
publishDate 2021-02-01
url http://www.sciencedirect.com/science/article/pii/S1201971220324929
work_keys_str_mv AT fangzheng replytonovaferontreatmentincovid19patients
AT yanwenzhou replytonovaferontreatmentincovid19patients
AT zhiguozhou replytonovaferontreatmentincovid19patients
AT feiye replytonovaferontreatmentincovid19patients
AT baoyinghuang replytonovaferontreatmentincovid19patients
AT yaxionghuang replytonovaferontreatmentincovid19patients
AT jingma replytonovaferontreatmentincovid19patients
AT qizuo replytonovaferontreatmentincovid19patients
AT xintan replytonovaferontreatmentincovid19patients
AT junxie replytonovaferontreatmentincovid19patients
AT peihuaniu replytonovaferontreatmentincovid19patients
AT wenlongwang replytonovaferontreatmentincovid19patients
AT yunxu replytonovaferontreatmentincovid19patients
AT fengpeng replytonovaferontreatmentincovid19patients
AT ningzhou replytonovaferontreatmentincovid19patients
AT chunlincai replytonovaferontreatmentincovid19patients
AT weitang replytonovaferontreatmentincovid19patients
AT xinqiangxiao replytonovaferontreatmentincovid19patients
AT yili replytonovaferontreatmentincovid19patients
AT zhiguangzhou replytonovaferontreatmentincovid19patients
AT yongfangjiang replytonovaferontreatmentincovid19patients
AT yuanlinxie replytonovaferontreatmentincovid19patients
AT wenjietan replytonovaferontreatmentincovid19patients
AT guozhonggong replytonovaferontreatmentincovid19patients
_version_ 1724281955089907712

Similar Items